Ophthalmic emulsion

US11690802B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11690802-B2
Application numberUS-202117200043-A
CountryUS
Kind codeB2
Filing dateMar 12, 2021
Priority dateDec 3, 2009
Publication dateJul 4, 2023
Grant dateJul 4, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is directed to an ophthalmic emulsion. The emulsion has a unique combination of ingredients that promotes the stability of small oil droplets within the emulsion. The emulsion also includes a mucoadhesive polymer that aid in delivering a lipid to the ocular surface.

First claim

Opening claim text (preview).

We claim: 1. An ophthalmic emulsion, the emulsion comprising: water forming an aqueous phase; oil forming an oil phase, wherein the oil is at least 0.1 w/v % and not greater than 5 w/v % of the emulsion; a hydrophilic surfactant having an HLB value of at least 8, wherein the hydrophilic surfactant is present in the emulsion in an amount that is at least 0.08 w/v % and no greater than 0.8 w/v %; a hydrophobic surfactant having an HLB value of below 8, wherein the hydrophobic surfactant is present in the emulsion in an amount that is at least 0.11 w/v % and no greater than 2.0 w/v %; an anionic phospholipid; borate; a mucoadhesive galactomannan polymer, wherein the mucoadhesive galactomannan polymer is present in the emulsion in a concentration of at least 0.01 w/v %, but no greater than 1.0 w/v %; wherein the emulsion is free of a benzalkonium chloride, wherein: i. the oil phase is in droplets within the aqueous phase and the droplets have an average diameter that is no greater than about 1000 nm, but is at least 10 nm, wherein the average diameter is corresponding to 90% of the cumulative undersize distribution by volume measured using a Microtrac S3500 Particle Size Analyzer (Software Version 10.3.1); and ii. the borate and galactomannan polymer cooperatively act to form a gel upon instillation of the emulsion in an eye of an individual. 2. The emulsion according to claim 1 wherein the oil is a hydrocarbon selected from mineral oil, paraffin oil and petrolatum. 3. The emulsion according to claim 1 wherein the hydrophilic surfactant is polyoxyethylene-40-stearate. 4. The emulsion according to claim 1 wherein the hydrophobic surfactant is a sorbitan tristearate. 5. The emulsion according to claim 1 wherein the mucoadhesive galactomannan polymer is selected from the group consisting of guar and hydroxypropyl guar. 6. The emulsion according to claim 1 wherein the anionic phospholipid is dimyristoyl phosphatidylglycerol. 7. The emulsion according to claim 1 wherein the phospholipid is present in the emulsion in a concentration from 0.05 to 7.0 percent by weight. 8. The emulsion according to claim 1 further comprising a borate/polyol buffer system. 9. The emulsion according to claim 1 wherein the oil phase is in droplets within the aqueous phase and the droplets have an average diameter that is no greater than 500 nm but is at least 100 nm, wherein the average diameter is corresponding to 90% of the cumulative undersize distribution by volume measured using a Microtrac S3500 Particle Size Analyzer (Software Version 10.3.1).

Assignees

Inventors

Classifications

  • Mixtures of compounds · CPC title

  • A61K9/0048Primary

    Eye, e.g. artificial tears · CPC title

  • Derivatives of phosphoric acid · CPC title

  • Use of substances as emulsifying, wetting, dispersing, or foam-producing agents · CPC title

  • A61K9/107Primary

    Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11690802B2 cover?
The present invention is directed to an ophthalmic emulsion. The emulsion has a unique combination of ingredients that promotes the stability of small oil droplets within the emulsion. The emulsion also includes a mucoadhesive polymer that aid in delivering a lipid to the ocular surface.
Who is the assignee on this patent?
Alcon Inc
What technology area does this patent fall under?
Primary CPC classification A61K9/0048. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).